Showing results (451-460 of 796) with videos related to

Sort By:
Pageof 80
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1995
Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patientsJ D Coplan, D Pine, L Papp, et al.
Biological Psychiatry|July 8, 1999
Elevation of CD5+ B lymphocytes in schizophreniaD J Printz, D H Strauss, R Goetz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1994
BMY 14802, a sigma receptor ligand for the treatment of schizophreniaG R Gewirtz, J M Gorman, J Volavka, et al.
The Review of Scientific Instruments|December 31, 2022
Broadband infrared confocal imaging for applications in additive manufacturingErin B Curry, Kaitlin C Lyszak, Donal Sheets, et al.
American Journal of Public Health|October 20, 2012
Mapping the spread of methamphetamine abuse in California from 1995 to 2008Paul J Gruenewald, William R Ponicki, Lillian G Remer, et al.
The American Journal of Psychiatry|June 1, 1988
Epinephrine infusions in patients with social phobiaL A Papp, J M Gorman, M R Liebowitz, et al.
Biological Psychiatry|May 10, 2001
Event-related brain potentials (ERPs) in schizophrenia for tonal and phonetic oddball tasksJ Kayser, G E Bruder, C E Tenke, et al.
The American Journal of Psychiatry|December 1, 1996
Schizoid personality disorder after prenatal exposure to famineH W Hoek, E Susser, K A Buck, et al.
The Journal of Nervous and Mental Disease|August 1, 1991
Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented cliniciansL A Welkowitz, L A Papp, M Cloitre, et al.
Behaviour Research and Therapy|November 27, 2013
Therapist effects and the outcome-alliance correlation in cognitive behavioral therapy for panic disorder with agoraphobiaJonathan D Huppert, Yogev Kivity, David H Barlow, et al.
Pageof 80